| Literature DB >> 32755585 |
Mandy Y Boontanrart1, Markus S Schröder2, Gautier M Stehli2, Marija Banović2, Stacia K Wyman3, Rachel J Lew1, Matteo Bordi2, Benjamin G Gowen1, Mark A DeWitt1, Jacob E Corn4.
Abstract
β-Hemoglobinopathies can trigger rapid production of red blood cells in a process known as stress erythropoiesis. Cellular stress prompts differentiating erythroid precursors to express high levels of fetal γ-globin. However, the mechanisms underlying γ-globin production during cellular stress are still poorly defined. Here, we use CRISPR-Cas genome editing to model the stress caused by reduced levels of adult β-globin. We find that decreased β-globin is sufficient to induce robust re-expression of γ-globin, and RNA sequencing (RNA-seq) of differentiating isogenic erythroid precursors implicates ATF4 as a causal regulator of this response. ATF4 binds within the HBS1L-MYB intergenic enhancer and regulates expression of MYB, a known γ-globin regulator. Overall, the reduction of ATF4 upon β-globin knockout decreases the levels of MYB and BCL11A. Identification of ATF4 as a key regulator of globin compensation adds mechanistic insight to the poorly understood phenomenon of stress-induced globin compensation and could inform strategies to treat hemoglobinopathies.Entities:
Keywords: BCL11A; CRISPR/Cas9; Fetal hemoglobin; HBS1L-MYB; adult hemoglobin; gene editing; hemoglobinopathies; stress erythropoiesis
Mesh:
Substances:
Year: 2020 PMID: 32755585 DOI: 10.1016/j.celrep.2020.107993
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423